Recent Updates
Recently added Catalysts
EBS Positive Sentiment

Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 2, 2023

Thursday, October 19, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Emergent BioSolutions Inc. will host a conference call on November 2, 2023, to discuss its financial results for the third quarter of 2023. The call will cover recent business developments and provide a financial outlook for the full year 2023. Participants can join via webcast or telephone, with registration required for telephone access. A replay will be available on the company's Investors page.
Price reaction · baseline $2.31 (2023-10-18 close) · hit after-hours · 1 other EBS headline(s) in the window, move may be shared
day 0 close · peak
-3.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Emergent BioSolutions will discuss recent business developments.
  • The company is providing a financial outlook for the full year 2023.
  • A live conference call offers a direct insight for investors.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+70%
120-day peak, hindsight
Typical move
8%
average across 2 past catalysts
Lead asset
FLU-IGIV
Phase 2 · Influenza A H3N2

Full Press Release Details

GAITHERSBURG, Md., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, November 2, 2023, at 5:00 pm eastern time to discuss the financial results for the third quarter of 2023, recent business developments, and financial outlook for full year 2023.
Conference Call Information
Participants can access the conference call live via webcast from the Investors page of Emergent’s website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.
A replay of the call can be accessed from the Investors page of Emergent’s website.
About Emergent BioSolutions
Executive Vice President, CFO

Frequently Asked Questions

When is the Emergent BioSolutions conference call scheduled?

The conference call is set for Thursday, November 2, 2023, at 5:00 pm ET.

How can I access the conference call?

Participants can join via webcast on the Investors page of Emergent's website.

Do I need to register to join the conference call?

Yes, telephone participants must register in advance to receive call details.

Where can I find the replay of the call?

A replay of the call will be available on Emergent's Investors page.

What will be discussed during the conference call?

The call will cover Q3 2023 financial results and business developments.

ShareAdd on Google
Tags: EBS Viatris Investor Conferences Healthcare Emergent BioSolutions financial results Q3 2023 conference call
Last updated: Oct 19, 2023

Biotech snapshot

Cash runway
$141M liquidity · $0M/mo burn
Low dilution risk
Lead asset
FLU-IGIVPhase 2
Influenza A H3N2 →

Catalyst track record

+70%
best trade around EBS's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for EBS.

See every catalyst's timing & PoA →